Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here’s a look at three names with significant upside potential, according to analysts.
Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here’s a look at three names with significant upside potential, according to analysts. Read More